查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1663306

介入性神经放射学 - 市场洞察、竞争格局、2032年市场预测

Interventional Neuroradiology - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2024年全球介入神经放射学市场规模价值 311.9887亿美元，预计到2032年将达到 520.8152亿美元，预测期内（2025-2032年）的年复合成长率为 6.66%。介入性神经放射学的需求主要由神经系统疾病发生率的上升所驱动，尤其是脑动脉瘤、缺血性中风和动静脉畸形（AVM）。这些疾病的日益普及推动了对微创诊断和治疗程序的需求，以改善患者的治疗效果并缩短恢復时间。

此外，技术进步将在预测期内（2025-2032年）推动市场成长发挥关键作用。下一代流量分流器、柔性微导管、增强成像技术和机器人辅助干预等发展显着提高了介入性神经放射学手术的准确性、安全性和有效性。这些进步使得以前被认为无法手术或手术有风险的复杂神经系统疾病能够得到治疗。

此外，人工智慧和机器学习演算法在诊断成像中的整合增强早期检测和治疗计划，加速介入神经放射学解决方案的采用。人们对微创手术的偏好日益增加，加上病患意识的提高和医疗保健基础设施的改善，进一步推动了各个地区的市场扩张。

介入性神经放射学的市场动态

由于神经系统疾病盛行率上升、中风发生率增加以及治疗设备技术的持续进步，介入性神经放射学市场预计在预测期内将大幅成长。

根据脑动脉瘤基金会（2023）的资料，美国约有 670万人患有未破裂的脑动脉瘤，每年报告的动脉瘤破裂病例约为 30,000 例。脑动脉瘤破裂可导致蛛网膜下腔出血等危及生命的病症，需要紧急介入治疗，例如血管内线圈栓塞或使用血流分流器。脑动脉瘤发生率的不断上升导致了人们认识的提高和诊断能力的提高，这因而又导致了对先进的介入性神经放射学（INR）设备的需求增加。早期发现和治疗可显着降低死亡率并改善长期效果，进一步推动市场成长。

中风疫情也是刺激市场需求的重要因素。根据《全球中风情形说明书（2022）》预测，2022年全球将发生约1,222万例中风，其中超过760万例为缺血性中风，占所有中风的62%。缺血性中风是由于动脉阻塞而发生的，而机械血栓切除术和支架取出术等介入性神经放射学技术对于恢復血流和降低长期残疾风险非常重要。及时介入可显着改善患者的復健和生存，推动 INR 技术在急性护理环境中的采用。

介入性神经放射学领域的技术创新进一步推动市场扩张。这些进展包括开发更灵活、更耐用、生物相容性的下一代支架和流量分流器，提高性能并减少支架内血栓形成和装置移位等併发症。此外，微导管和微导丝的技术创新提高了脑部复杂血管网路导航的精确度和成功率，可以更安全、更有效地治疗复杂的动脉瘤和动静脉畸形（AVM）。机器人辅助干预和即时成像等尖端技术也使微创手术成为可能，可缩短恢復时间并降低风险，越来越受到患者和医疗保健提供者的欢迎。

儘管存在这些积极因素，但市场仍面临着与介入设备相关的併发症（如血管穿孔、设备移位和血栓栓塞）以及设备审批的监管环境挑战等挑战。监管机构需要大量临床资料来确保安全性和有效性，这可能会延迟产品发布并增加开发成本。

然而，全球神经和脑血管疾病负担不断加重、人们对早期干预益处的认识不断提高以及技术的持续进步预计将克服挑战并推动2025-2032年预测期内介入神经放射学市场的成长。

本报告对全球介入神经放射学市场进行调查分析，包括市场规模和预测、过去三年的产品/技术发展、市场的主要参与者以及可用的机会。

目录

第1章 介入性神经放射学市场报告简介

第2章 介入性神经放射学市场执行摘要

  • 市场概况

第3章 竞争格局

第4章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 介入性神经放射学市场关键因素分析

  • 介入性神经放射学市场驱动因素
  • 介入性神经放射学市场的限制与挑战
  • 介入性神经放射学市场机会

第6章 介入性神经放射学市场的波特五力分析

第7章 介入性神经放射学市场评估

  • 依设备
    • 微导丝
    • 微导管
    • 导流支架
    • 栓塞线圈
    • 神经血管栓塞装置
    • 其他
  • 疾病
    • 脑动脉瘤
    • 颅内肿瘤
    • 急性缺血性中风
    • 其他疾病
  • 依最终用户
    • 医院
    • 门诊手术中心
  • 区域
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 介入性神经放射学市场中的公司与产品概况

  • Stryker
  • Boston Scientific Corporation
  • MicroVention Inc.
  • Cook
  • Mediterra
  • Johnson & Johnson, Inc.
  • Merit Medical Systems, Inc.
  • Terumo Corporation
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Balt Group
  • AngioDynamics
  • Acandis GmBH
  • Phenox GmbH
  • InspireMD Inc.

第9章 KOL 视角

第10章 专案方法

第11章 关于 DelveInsight

第12章 免责声明、联络我们

Product Code: DIMDCL0065

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of neurological disorders such as cerebral aneurysms and growing technical advancements in the domain of interventional neuroradiology

The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032. The demand for interventional neuroradiology is primarily driven by the rising incidence of neurological disorders, particularly cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs). The growing prevalence of these conditions has heightened the need for minimally invasive diagnostic and therapeutic procedures to improve patient outcomes and reduce recovery times.

Additionally, advancements in technology are playing a pivotal role in propelling market growth during the forecast period (2025 to 2032). Innovations such as the development of next-generation flow diversion devices, highly flexible microcatheters, enhanced imaging technologies, and robot-assisted interventions have significantly improved the precision, safety, and efficacy of interventional neuroradiology procedures. These advancements have enabled the treatment of complex neurological conditions that were previously considered inoperable or carried higher surgical risks.

Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging is enhancing early detection and treatment planning, thereby driving the adoption of interventional neuroradiology solutions. The increasing preference for minimally invasive procedures, combined with rising patient awareness and improved healthcare infrastructure, is further accelerating market expansion across various regions.

Interventional Neuroradiology Market Dynamics:

The interventional neuroradiology market is projected to experience significant growth during the forecast period, driven by the rising prevalence of neurological disorders, increasing incidence of strokes, and ongoing technological advancements in treatment devices.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the United States have an unruptured brain aneurysm, with around 30,000 cases of aneurysm rupture reported annually. Brain aneurysm ruptures can lead to life-threatening conditions such as subarachnoid hemorrhage and require urgent interventional procedures like endovascular coiling or the use of flow diverters. The increasing prevalence of brain aneurysms has resulted in heightened awareness, improved diagnostic capabilities, and a corresponding rise in demand for advanced interventional neuroradiology (INR) devices. Early detection and treatment significantly reduce mortality and improve long-term outcomes, further propelling market growth.

Stroke prevalence is another critical factor fueling market demand. According to the Global Stroke Fact Sheet (2022), there were approximately 12.22 million incident stroke cases globally in 2022, with over 7.6 million ischemic strokes accounting for 62% of all strokes. Ischemic strokes occur due to blocked arteries, and interventional neuroradiology techniques such as mechanical thrombectomy and stent retrievers are essential in restoring blood flow and reducing the risk of long-term disability. Timely interventions significantly improve patient recovery and survival rates, which has boosted the adoption of INR procedures across emergency care settings.

Technological innovations in the interventional neuroradiology field further support market expansion. Advancements include the development of next-generation stents and flow diverters with improved flexibility, durability, and biocompatibility, which enhance performance and reduce complications such as in-stent thrombosis or device migration. Moreover, innovations in microcatheter and microguidewire technologies have improved precision and navigability through the brain's complex vascular network, allowing for safer and more effective treatment of complex aneurysms and arteriovenous malformations (AVMs). Cutting-edge technologies like robot-assisted interventions and real-time imaging advancements are also enabling minimally invasive procedures with shorter recovery times and reduced risks, which are becoming increasingly preferred by both patients and healthcare providers.

Despite these positive drivers, the market faces challenges such as complications associated with interventional devices (e.g., vessel perforation, device migration, or thromboembolic events) and the stringent regulatory landscape for device approval. Regulatory authorities require extensive clinical data to ensure safety and efficacy, which can delay product launches and increase development costs.

Nevertheless, the rising global burden of neurological and cerebrovascular diseases, increasing awareness of early intervention benefits, and continuous technological progress are expected to outweigh the challenges, thereby propelling the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

Interventional Neuroradiology Market Segment Analysis:

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the interventional neuroradiology market, the flow diversion stents category is projected to amass a significant revenue share in 2024, driven by their versatile applications, clinical advantages, and increasing product approvals that are collectively fueling market demand during the forecast period.

Flow diversion stents have emerged as a preferred treatment option for managing complex intracranial aneurysms, particularly those that are large, wide-necked, or fusiform cases that are challenging to treat with traditional methods such as endovascular coiling. These stents work by redirecting blood flow away from the aneurysm sac, promoting endothelial growth along the stent, and ultimately sealing off the aneurysm over time. Flow diversion therapy is especially beneficial for aneurysms that have recurred after previous treatments, offering a reliable alternative with long-term durability and lower recurrence rates.

One of the key benefits of flow diversion stents is their minimally invasive nature. The procedure is typically performed using a catheter-based delivery system through the femoral or radial artery, reducing the risks associated with open craniotomy and shortening recovery times. Unlike traditional coiling, direct manipulation of the aneurysm sac is avoided, significantly reducing the risk of rupture during the procedure. Moreover, many flow diversion techniques do not require adjunctive devices like coils or balloons, simplifying the intervention process and minimizing device-related complications.

The market growth for flow diversion stents is further fueled by a surge in product approvals and technological advancements. For instance, in December 2023, MicroPort(R) NeuroTech(TM) received approval from the Brazilian National Health Surveillance Agency (ANVISA) for its Tubridge(R) Vascular Reconstruction Device. The Tubridge(R) is a dense-mesh stent applying flow diversion therapy principles, designed specifically to treat large or giant wide-necked intracranial aneurysms. Such innovations offer improved device flexibility, better wall apposition, and enhanced navigability through tortuous cerebral vessels, making them suitable for treating complex cases with greater precision and safety.

Additionally, the rising prevalence of intracranial aneurysms, increased awareness of early diagnosis, and growing demand for minimally invasive interventions are key contributors to the expanding market share of flow diversion stents. As more healthcare facilities adopt these advanced devices and as clinical guidelines increasingly support their use for various aneurysm types, the adoption rate is expected to rise globally.

Therefore, owing to the aforementioned factors including their clinical efficacy, safety profile, technological advancements, and regulatory approvals the flow diversion stents category is poised to register significant growth, thereby driving the overall expansion of the interventional neuroradiology market during the forecast period (2025 to 2032).

North America is expected to dominate the overall interventional neuroradiology market:

North America is anticipated to account for the largest share of the interventional neuroradiology market in 2024, driven by a large patient pool affected by ischemic strokes, transient ischemic attacks (TIA), and a growing geriatric population. Additional factors such as advanced healthcare infrastructure, technological innovations, and robust product development pipelines are further propelling market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) 2023, approximately 795,000 people in the United States experience a stroke each year, with 87% being ischemic strokes caused by a blockage of blood flow to the brain. The high prevalence of ischemic strokes, coupled with the need for rapid intervention to improve patient outcomes, has increased the demand for interventional neuroradiology devices, including mechanical thrombectomy devices, stent retrievers, and aspiration catheters.

The aging population in North America further contributes to the rising incidence of strokes and TIAs. According to the US Census Bureau 2021 report, over 54 million adults aged 65 and older were living in the United States in 2021. This demographic is expected to rise to approximately 85.7 million by 2050, representing nearly 20% of the overall US population. The elderly population, particularly those above 50 years, are at a higher risk of ischemic strokes and TIA due to age-related vascular changes such as arterial narrowing, arteriosclerosis, and atherosclerosis. This underscores the growing need for minimally invasive treatments to manage these conditions effectively.

Additionally, the high adoption rate of innovative technologies and the presence of major market players in the region foster continuous product launches and regulatory approvals. For example, the United States Food and Drug Administration (FDA) has expedited the approval of various neurovascular devices to enhance stroke care. The region's robust research and development activities, favorable reimbursement policies, and widespread use of advanced imaging technologies further support early diagnosis and prompt intervention, contributing to market expansion.

The strategic collaborations between healthcare providers, academic institutions, and medical device manufacturers in North America also play a crucial role in accelerating product innovations and expanding treatment accessibility. Moreover, the increasing awareness of stroke symptoms and improved emergency medical services are enabling faster treatment initiation, which is critical in ischemic stroke management.

Therefore, the combination of a growing stroke patient population, an aging demographic, technological advancements, and a supportive regulatory environment positions North America as the leading region in the interventional neuroradiology market during the forecast period (2025 to 2032).

Interventional Neuroradiology Market Key Players:

Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

Recent Developmental Activities in the Interventional Neuroradiology Market:

  • In October 2023, the Royal Australian and New Zealand College of Radiologists (RANZCR) launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology during its 72nd Annual Scientific Meeting (ASM) held in Adelaide. These standards aim to enhance patient safety, optimize clinical outcomes, and ensure consistent quality of care in interventional radiology and neuroradiology procedures across the region.
  • In June 2022, Stryker announced a partnership with Carmeda to develop an advanced flow diverter featuring active drug coating technology. This collaboration aims to enhance aneurysm treatment by improving device biocompatibility and reducing the risk of thrombosis, ultimately offering better long-term patient outcomes in the management of complex cerebral aneurysms.

Key Takeaways from the Interventional Neuroradiology Market Report Study

  • Market size analysis for current interventional neuroradiology market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the interventional neuroradiology market.
  • Various opportunities available for the other competitors in the interventional neuroradiology market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current interventional neuroradiology market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for interventional neuroradiology market growth in the coming future?

Target Audience Who Can be Benefited from this Interventional Neuroradiology Market Report Study

  • Interventional neuroradiology product providers
  • Research organizations and consulting companies
  • Interventional Neuroradiology - related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in the interventional neuroradiology market
  • Various end-users who want to know more about the interventional neuroradiology market and the latest technological developments in the interventional neuroradiology market.

Frequently Asked Questions for the Interventional Neuroradiology Market:

1. What is meant by interventional neuroradiology?

  • Interventional Neuroradiology is a subspecialty of radiology that focuses on diagnosing and treating disorders of the central nervous system (CNS), including the brain, spine, head, and neck. It combines expertise in neuroanatomy, imaging techniques, and endovascular (within the blood vessels) methods.

2. What is the market for interventional neuroradiology?

  • The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032.

3. What are the drivers for the global interventional neuroradiology market?

  • The interventional neuroradiology market is primarily being boosted by the rising incidence of neurological disorders such as cerebral aneurysms. Additionally, increasing technological advancements in the domain of interventional neuroradiology is another key factor, which is responsible for contributing to the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global interventional neuroradiology market?

  • Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

5. Which region has the highest share in the global interventional neuroradiology market?

  • North America is expected to dominate the overall interventional neuroradiology market during the forecast period, 2025 to 2032. This is due to the presence of a large patient pool suffering from ischemic stroke, and transient ischemic attack (TIA). Additionally, the rising geriatric population, the presence of developed and sophisticated healthcare infrastructure, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the interventional neuroradiology market in North America.

Table of Contents

1. Interventional Neuroradiology Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Interventional Neuroradiology Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Interventional Neuroradiology Market Key Factors Analysis

  • 5.1. Interventional Neuroradiology Market Drivers
    • 5.1.1. Rising prevalence of neurological disorders
    • 5.1.2. Growing technical advancements and Innovation
    • 5.1.3. Growing Government Initiatives and favorable Reimbursement policies
  • 5.2. Interventional Neuroradiology Market Restraints and Challenges
    • 5.2.1. Complications associated with the use of interventional neuroradiology devices
    • 5.2.2. Stringent regulatory approval of the devices
  • 5.3. Interventional Neuroradiology Market Opportunities
    • 5.3.1. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging for enhancing early detection and treatment planning

6. Interventional Neuroradiology Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Interventional Neuroradiology Market Assessment

  • 7.1. By Device
    • 7.1.1. Micro guidewires
    • 7.1.2. Microcatheters
    • 7.1.3. Flow Diversion Stents
    • 7.1.4. Embolization Coils
    • 7.1.5. Neurovascular Embolization Devices
    • 7.1.6. Others
  • 7.2. By Disease
    • 7.2.1. Cerebral Aneurysms
    • 7.2.2. Intracranial Tumors
    • 7.2.3. Acute Ischemic Strokes
    • 7.2.4. Other Diseases
  • 7.3. By End-Users
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.3. India Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Interventional Neuroradiology Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Interventional Neuroradiology Market Size in USD million (2022-2032)

8. Interventional Neuroradiology Market Company and Product Profiles

  • 8.1. Stryker
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. MicroVention Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Cook
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Mediterra
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Johnson & Johnson, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Merit Medical Systems, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Terumo Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Penumbra, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MicroPort Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Balt Group
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. AngioDynamics
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Acandis GmBH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Phenox GmbH
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. InspireMD Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Interventional Neuroradiology Market in Global (2022-2032)
  • Table 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
  • Table 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
  • Table 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
  • Table 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
  • Table 7: Interventional Neuroradiology Market in North America (2022-2032)
  • Table 8: Interventional Neuroradiology Market in the United States (2022-2032)
  • Table 9: Interventional Neuroradiology Market in Canada (2022-2032)
  • Table 10: Interventional Neuroradiology Market in Mexico (2022-2032)
  • Table 11: Interventional Neuroradiology Market in Europe (2022-2032)
  • Table 12: Interventional Neuroradiology Market in France (2022-2032)
  • Table 13: Interventional Neuroradiology Market in Germany (2022-2032)
  • Table 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
  • Table 15: Interventional Neuroradiology Market in Italy (2022-2032)
  • Table 16: Interventional Neuroradiology Market in Spain (2022-2032)
  • Table 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
  • Table 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
  • Table 19: Interventional Neuroradiology Market in China (2022-2032)
  • Table 20: Interventional Neuroradiology Market in Japan (2022-2032)
  • Table 21: Interventional Neuroradiology Market in India (2022-2032)
  • Table 22: Interventional Neuroradiology Market in Australia (2022-2032)
  • Table 23: Interventional Neuroradiology Market in South Korea (2022-2032)
  • Table 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
  • Table 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
  • Table 27: Interventional Neuroradiology Market in Africa (2022-2032)
  • Table 28: Interventional Neuroradiology Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Interventional Neuroradiology Market in Global (2022-2032)
  • Figure 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
  • Figure 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
  • Figure 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
  • Figure 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
  • Figure 7: Interventional Neuroradiology Market in North America (2022-2032)
  • Figure 8: Interventional Neuroradiology Market in the United States (2022-2032)
  • Figure 9: Interventional Neuroradiology Market in Canada (2022-2032)
  • Figure 10: Interventional Neuroradiology Market in Mexico (2022-2032)
  • Figure 11: Interventional Neuroradiology Market in Europe (2022-2032)
  • Figure 12: Interventional Neuroradiology Market in France (2022-2032)
  • Figure 13: Interventional Neuroradiology Market in Germany (2022-2032)
  • Figure 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
  • Figure 15: Interventional Neuroradiology Market in Italy (2022-2032)
  • Figure 16: Interventional Neuroradiology Market in Spain (2022-2032)
  • Figure 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
  • Figure 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
  • Figure 19: Interventional Neuroradiology Market in China (2022-2032)
  • Figure 20: Interventional Neuroradiology Market in Japan (2022-2032)
  • Figure 21: Interventional Neuroradiology Market in India (2022-2032)
  • Figure 22: Interventional Neuroradiology Market in Australia (2022-2032)
  • Figure 23: Interventional Neuroradiology Market in South Korea (2022-2032)
  • Figure 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
  • Figure 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
  • Figure 27: Interventional Neuroradiology Market in Africa (2022-2032)
  • Figure 28: Interventional Neuroradiology Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis